BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Optimizing Access to Care ALS Patient #1 - Newly Diagnosed

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Friday, May 1, 2020
Sponsor Information: 

Supported in part by an independent educational grant from Mitsubishi Tanabe Pharma America, Inc.

Faculty

Lora L. Clawson, MSN, CRNP
Lora L. Clawson, MSN, CRNP
Assistant Professor of Neurology, Director of ALS Clinical Services, Johns Hopkins Hospital
Optimizing Access to Care ALS Patient #1 - Newly Diagnosed
Activity Overview: 

This case study will explore optimizing care for ALS in patient #1 (52-year-old female) who is newly diagnosed.

Learning Objectives: 

Patient Access to Treatment in ALS Case Study:

  • Coordinate care and access to all available treatments
  • Help ensure coverage of therapies and devices
  • Help your patient appeal a reimbursement decision